Adipocytokines during pregnancy and postpartum in women with gestational diabetes and healthy controls

Journal of Endocrinological Investigation

Volumn 36, Issue 11, 2013, Pages 944-949

  Boyadzhieva, M ^a   Atanasova, I ^a   Zacharieva, S ^a   Kedikova, S ^b  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b University Hospital of Obstetrics and Gynecology 'Maichin Dom' Bulgaria   (Bulgaria)

Author keywords

Adipocytokines; Adiponectin; Apelin; Gestational diabetes; Leptin; Resistin; Visfatin

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; APELIN; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RESISTIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PUERPERIUM;

ADIPOKINES; ADIPONECTIN; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES, GESTATIONAL; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; POSTPARTUM PERIOD; PREGNANCY;

EID: 84891689843     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/8968     Document Type: Article

References (38)

1. Sun WJ, Yang HX. Maternal and fetal outcomes in pregnant women with abnormal glucose metabolism. Zhonghua Fu Chan Ke Za Zhi 2007, 42: 377-81.
2. Metzger BE, Buchanan TA, Coustan DR, et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 2007, 30 (Suppl 2): S251-60.
3. Miehle K, Stepan H, Fasshauer M. Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia. Clin Endocrinol (Oxf) 2012, 76: 2-11.
4. Valsamakis G, Kumar S, Creatsas G, Mastorakos G. The effects of adipose tissue and adipocytokines in human pregnancy. Ann NY Acad Sci 2010, 1205: 76-81.
5. Vitoratos N, Deliveliotou A, Vlahos NF, et al. Serum adiponectin during pregnancy and postpartum in women with gestational diabetes and normal controls. Gynecol Endocrinol 2008, 24: 614-9.
6. Briana DD, Malamitsi-Puchner A. Reviews: adipocytokines in normal and complicated pregnancies. Reprod Sci 2009, 16: 921-37.
7. Lacquemant C, Vasseur F, Lepretre F, Froguel P. Adipocytokines, obesity and development of type 2 diabetes. Med Sci (Paris) 2003, 19: 809-17.
8. Wiecek A, Adamczak M, Chudek J. Adiponectin - an adipokine with unique metabolic properties. Nephrol Dial Transplant 2007, 22: 981-8.
9. Horosz E, Bomba-Opon DA, Szymanska M, Wielgos M. Third trimester plasma adiponectin and leptin in gestational diabetes and normal pregnancies. Diabetes Res Clin Pract 2011, 93: 350-6.
10. Worda C, Leipold H, Gruber C, Kautzky-Willer A, Knofler M, Bancher-Todesca D. Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus. Am J Obstet Gynecol 2004, 191: 2120-4.
11. Liu T, Liu Q, Yang D, Fang Z. Relationship of serum levels of adiponectin, leptin, tumor necrosis factor-alpha and c-reactive protein with insulin resistance during first trimester pregnancy. Zhonghua Yi Xue Za Zhi 2011, 91: 1058-60.
12. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 2001, 60: 329-39.
13. Sattar N, Greer IA, Pirwani I, Gibson J, Wallace AM. Leptin levels in pregnancy: marker for fat accumulation and mobilization? Acta Obstet Gynecol Scand 1998, 77: 278-83.
14. Wang Q, Guo T, Tao Y, Song Y, Huang W. Association between serum adipocyte factor level and insulin resistance in polycystic ovarian syndrome. Gynecol Endocrinol 2011, 27: 931-4.
15. Wauters M, Considine RV, Van Gaal LF. Human leptin: from an adipocyte hormone to an endocrine mediator. Eur J Endocrinol 2000, 143: 293-311.
16. Steppan CM, Lazar MA. The current biology of resistin. J Intern Med 2004, 255: 439-47.
17. Vitoratos N, Deliveliotou A, Dimitrakaki A, et al. Maternal serum resistin concentrations in gestational diabetes mellitus and normal pregnancies. J Obstet Gynaecol Res 2011, 37: 112-8.
18. Kourtis A, Gkiomisi A, Mouzaki M, et al. Apelin levels in normal pregnancy. Clin Endocrinol 2011, 75: 367-71.
19. Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005, 307: 426-30.
20. Szamatowicz J, Kuzmicki M, Telejko B, et al. Serum visfatin concentration is elevated in pregnant women irrespectively of the presence of gestational diabetes. Ginekol Pol 2009, 80: 14-8.
21. Metzger BE, Gabbe SG, Persson B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010, 33: 676-82.
22. Report of WHO/IDF consultation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia, 2006.
23. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001, 86:1930-5.
24. Schondorf T, Maiworm A, Emmison N, Forst T, Pfutzner A. Biological background and role of adiponectin as marker for insulin resistance and cardiovascular risk. Clin Lab 2005, 51: 489-94.
25. Saucedo R, Zarate A, Basurto L, et al. Relationship between circulating adipokines and insulin resistance during pregnancy and postpartum in women with gestational diabetes. Arch Med Res 2011, 42: 318-23.
26. Cortelazzi D, Corbetta S, Ronzoni S, et al. Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin Endocrinol 2007, 66: 447-53.
27. Gao XL, Yang HX, Zhao Y. Variations of tumor necrosis factor-alpha, leptin and adiponectin in mid-trimester of gestational diabetes mellitus. Chin Med J 2008, 121: 701-5.
28. McLachlan KA, O'Neal D, Jenkins A, Alford FP. Do adiponectin, TNF-alpha, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy. Diabetes Metab Res Rev 2006, 22: 131-8.
29. Roca-Rodriguez MM, Lopez-Tinoco C, Fernandez-Deudero A, et al. Adipokines and metabolic syndrome risk factors in women with previous gestational diabetes mellitus. Diabetes Metab Res Rev 2012, 28: 542-8.
30. Butte NF, Hopkinson JM, Nicolson MA. Leptin in human reproduction: serum leptin levels in pregnant and lactating women. J Clin Endocrinol Metab 1997, 82: 585-9.
31. Telejko B, Kuzmicki M, Wawrusiewicz-Kurylonek N, et al. Plasma apelin levels and apelin/APJ mRNA expression in patients with gestational diabetes mellitus. Diabetes Res Clin Pract 2010, 87: 176-83.
32. Boucher J, Masri B, Daviaud D, et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 2005, 146: 1764-71.
33. Castan-Laurell I, Dray C, Attane C, Duparc T, Knauf C, Valet P. Apelin, diabetes, and obesity. Endocrine 2011, 40: 1-9.
34. Megia A, Vendrell J, Gutierrez C, et al. Insulin sensitivity and resistin levels in gestational diabetes mellitus and after parturition. Eur J Endocrinol 2008, 158: 173-8.
35. Haider DG, Handisurya A, Storka A, et al. Visfatin response to glucose is reduced in women with gestational diabetes mellitus. Diabetes Care 2007, 30: 1889-91.
36. Soheilykhah S, Mohammadi M, Mojibian M, et al. Maternal serum adiponectin concentration in gestational diabetes. Gynecol Endocrinol 2009, 25: 593-6.
37. Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia 2003, 46: 1594-603.
38. Tsai PJ, Yu CH, Hsu SP, et al. Maternal plasma adiponectin concentrations at 24 to 31 weeks of gestation: negative association with gestational diabetes mellitus. Nutrition 2005, 21: 1095-9.